Q3 FY2026
Filed Oct 8, 2026Thirteenth Consecutive Quarter of Growth Ahead of Major Wholesale Launches
Preliminary Q3 2026 net sales reached the Company’s highest quarterly level, rising approximately 55% year over year, while new U.S., Canadian, Australian and New Zealand channel launches position wholesale sales to become more meaningful beginning in Q4 2026.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Preliminary net sales, Q3 2026other | approximately $1.04 million | – | approximately 55% |
| Preliminary net sales, nine months ended September 30, 2026other | approximately $2.8 million | – | approximately 66% |
| Net sales, full year ended December 31, 2025other | $2.66M | – | – |
Q4 2026 and 2027 outlook
- NoteThe wholesale expansion is expected to have a more meaningful effect on net sales beginning in the fourth quarter of 2026 and into 2027.
- NoteThe retailer plans to offer the products in more than 150 of its stores nationwide, with in-store sales expected to begin in October 2026.
- NoteThe orders are expected to ship in October 2026 and are not included in third quarter net sales.
- NoteThe Company expects to report its full third quarter 2026 financial results in mid-November 2026 with the filing of its Quarterly Report on Form 10-Q.
What drove it
- Third quarter growth reflected an increase of approximately 25% in direct-to-consumer and online marketplace sales and the first shipments under the Company’s new wholesale programs.
- In September, the Company received and shipped an initial purchase order from one of the largest big-box retailers in the U.S. for its previously announced Lucyd Armor rollout.
- The retail launch with FYihealth Group commenced during the third quarter, with product placement underway across approximately 345 locations.
- The Company received initial purchase orders for more than 3,000 smart eyewear units from Directed Electronics, its exclusive distributor for Australia and New Zealand.
- Management said it was running promotional pricing on older models and conserving advertising and marketing spend ahead of the planned fourth quarter launch of Lucyd Aero.
Concerns
- The preliminary net sales figures are unaudited estimates and remain subject to completion of quarter-end financial close procedures and review of interim financial statements.
- Actual results may differ materially from the preliminary estimates.
- The more than 3,000-unit Directed Electronics orders are expected to ship in October 2026 and are not included in third quarter net sales.
- The filing identifies risks related to timing and volume of orders, reorders, shipments and sell-through, market acceptance of new products, additional financing, going-concern status and Nasdaq continued-listing compliance.
What to watch
- Completion of the Company’s Q3 2026 financial close and review of interim financial statements before the anticipated mid-November 2026 Form 10-Q filing.
- In-store sales expected to begin in October 2026 at more than 150 U.S. big-box retailer locations.
- The timing of Directed Electronics shipments in October 2026.
- Restocks and product placement across approximately 345 FYihealth Group locations.
- The planned fourth quarter launch of Lucyd Aero and the expected effect of wholesale expansion on net sales.
Analysis
Innovative Eyewear reported preliminary unaudited Q3 2026 net sales of approximately $1.04 million, up approximately 55% over Q3 2025 and described as the highest quarterly net sales in the Company’s history. The Company also cited its thirteenth consecutive quarter of year-over-year revenue growth. These results are preliminary estimates, remain subject to completion of the quarter-end close and review of interim financial statements, and may differ materially from the stated figures.
For the nine months ended September 30, 2026, preliminary net sales were approximately $2.8 million, an increase of approximately 66% over the comparable 2025 period. The Company stated that this nine-month total already exceeds its $2.66 million of net sales for the full year ended December 31, 2025. Management noted that the fourth quarter has historically been the Company’s strongest quarter.
The quarter’s reported growth reflected an approximately 25% increase in direct-to-consumer and online marketplace sales, together with initial shipments under new wholesale programs. Management said it intentionally used promotional pricing on older models and conserved advertising and marketing spend. The release provides no gross margin, operating expense, operating income, net income, EPS, or cash flow figures, so the effect of these actions on profitability and cash generation is not disclosed.
Channel expansion is the central forward catalyst in the release. A major U.S. big-box retailer received and shipped its initial Lucyd Armor purchase order, with more than 150 stores expected to begin in-store sales in October 2026. FYihealth Group’s Canadian rollout commenced during the quarter across approximately 345 locations, while Directed Electronics placed initial orders for more than 3,000 units for Australia and New Zealand. Those Directed Electronics orders are expected to ship in October 2026 and were not included in Q3 net sales. The Company expects wholesale expansion to have a more meaningful effect beginning in Q4 2026 and into 2027, but it provided no quantitative revenue or profitability outlook.
Management, verbatim
Our preliminary third quarter results reflect continued progress in executing our growth strategy. We delivered the highest quarterly net sales in our history while intentionally running promotional pricing on older models and conserving advertising and marketing spend. That approach clears the way for the planned fourth quarter launch of Lucyd Aero™, our lightest and most advanced smartglasses to date, as we head into what has historically been our strongest quarter of the year. At the same time, we opened three new wholesale and international channels during the quarter: a major U.S. big-box retailer, FYihealth Group in Canada, and Directed Electronics in Australia and New Zealand. We anticipate that these new channels will enhance our growth in the fourth quarter of 2026 and into 2027.
Harrison Gross, CEO of Innovative Eyewear
Not in the filing
stated, not guessed- Exact Q3 2025 net sales for the Q3 2026 net-sales comparison
- Exact nine-month net sales for the nine months ended September 30, 2025
- Q2 2026 net sales and sequential net-sales comparison
- Gross profit and gross margin
- Operating expenses
- Operating income or loss
- Net income or loss
- GAAP and non-GAAP EPS
- Operating cash flow and free cash flow
- Cash, debt and liquidity balances
- Share repurchases, dividends and other capital returns
- Segment revenue and segment profitability
- Quantitative Q4 2026 or 2027 revenue guidance
- Quantitative gross-margin, operating-expense and tax-rate guidance
- Prior guidance for comparison
AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.